東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Controversies in cardiology

Ambrose, John A.

FindBook

Google Book

Amazon

博客來

Controversies in cardiology

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Controversies in cardiology/ edited by John A. Ambrose, Alfredo E. Rodriguez.
其他作者:	Ambrose, John A.
出版者:	Cham :Springer International Publishing : : 2015.,
面頁冊數:	xviii, 417 p. :ill. (some col.), digital ;24 cm.
內容註:	Section 1. Special situations of controversial, increased, or unknown cardiovascular risk -- Optimal management of old and new CV risk factors -- Angiographic narrowing prior to ST elevation MI. Are the lesions non-obstructive? -- Preventing future acute coronary events - Identify and treat vulnerable plaques or vulnerable, high risk patients? -- Treatment of diabetes and coronary artery disease -- Elevated triglycerides and atherosclerosis -- Patent foramen ovale and stroke -- Systolic hypertension in the elderly -- Section 2. Cardiovascular diagnosis -- CT angiography vs routine stress testing in patients with chest pain seen in the emergency room to exclude coronary artery disease -- Takotsubo cardiomyopathy- frequency, diagnosis and management -- Chest pain in women - evaluation and management -- Section 3. Cardiovascular management -- Myocardial infarction and "normal" coronary arteries on angiography -- Management of intractable angina when PCI or CABG is not an option -- Invasive management of CAD in patients on anticoagulants -- Managing intracoronary thrombus during PCI -- Optimal management of multivessel disease - PCI vs CABG vs medical therapy alone -- Appropriate therapy for severe left main disease -- Radial vs femoral procedures for angiography and PCI -- DAPT after stenting in stable and acute coronary syndromes - does the drug combination really matter? -- CAD management in patients with significant renal dysfunction or on dialysis -- What is the optimal stent design? -- Oral pharmacotherapy in the prevention of restenosis: prednisolone, rapamune, colchicine and cilostazol -- When should ablation be considered in the treatment of atrial fibrillation? -- Use of advanced and expensive cardiac procedures in the very elderly- Can or should we limit access? -- Cost benefits of TAVR- Should the indications be expanded?
Contained By:	Springer eBooks
標題:	Cardiology. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-20415-4
ISBN:	9783319204154

Controversies in cardiology
Controversies in cardiology[electronic resource] /edited by John A. Ambrose, Alfredo E. Rodriguez. - Cham :Springer International Publishing :2015. - xviii, 417 p. :ill. (some col.), digital ;24 cm.

Section 1. Special situations of controversial, increased, or unknown cardiovascular risk -- Optimal management of old and new CV risk factors -- Angiographic narrowing prior to ST elevation MI. Are the lesions non-obstructive? -- Preventing future acute coronary events - Identify and treat vulnerable plaques or vulnerable, high risk patients? -- Treatment of diabetes and coronary artery disease -- Elevated triglycerides and atherosclerosis -- Patent foramen ovale and stroke -- Systolic hypertension in the elderly -- Section 2. Cardiovascular diagnosis -- CT angiography vs routine stress testing in patients with chest pain seen in the emergency room to exclude coronary artery disease -- Takotsubo cardiomyopathy- frequency, diagnosis and management -- Chest pain in women - evaluation and management -- Section 3. Cardiovascular management -- Myocardial infarction and "normal" coronary arteries on angiography -- Management of intractable angina when PCI or CABG is not an option -- Invasive management of CAD in patients on anticoagulants -- Managing intracoronary thrombus during PCI -- Optimal management of multivessel disease - PCI vs CABG vs medical therapy alone -- Appropriate therapy for severe left main disease -- Radial vs femoral procedures for angiography and PCI -- DAPT after stenting in stable and acute coronary syndromes - does the drug combination really matter? -- CAD management in patients with significant renal dysfunction or on dialysis -- What is the optimal stent design? -- Oral pharmacotherapy in the prevention of restenosis: prednisolone, rapamune, colchicine and cilostazol -- When should ablation be considered in the treatment of atrial fibrillation? -- Use of advanced and expensive cardiac procedures in the very elderly- Can or should we limit access? -- Cost benefits of TAVR- Should the indications be expanded?

This book considers several clinical and interventional topics for which there is either uncertainty, continued debate and/or no consensus based on current guidelines. Leading international experts explore each controversy, probing the existing evidence and current opinions. Each chapter outlines the unresolved issues and includes a balanced and scholarly discussion of the subject, concluding with possible solutions and learned opinions on the subject. While there are many guidelines in cardiology, new and on-going trials that address new treatments indicate that there are still many unanswered questions. Controversies in Cardiology provides a concise approach to aid busy cardiologists and trainees in choosing the most suitable management solutions and correctly applying these to their patients.

ISBN: 9783319204154

Standard No.: 10.1007/978-3-319-20415-4doiSubjects--Topical Terms:

861477
Cardiology.

LC Class. No.: RC667

Dewey Class. No.: 616.12

Controversies in cardiology
LDR:03597nmm a2200313 a 4500 001 2013634
003 DE-He213
005 20160408155406.0
006 m d
007 cr nn 008maaau
008 160518s2015 gw s 0 eng d
020 $a 9783319204154 $q (electronic bk.)
020 $a 9783319204147 $q (paper)
024 7 $a 10.1007/978-3-319-20415-4 $2 doi
035 $a 978-3-319-20415-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC667
072 7 $a MJD $2 bicssc
072 7 $a MED010000 $2 bisacsh
082 0 4 $a 616.12 $2 23
090 $a RC667 $b .C764 2015
245 0 0 $a Controversies in cardiology $h [electronic resource] / $c edited by John A. Ambrose, Alfredo E. Rodriguez.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a xviii, 417 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Section 1. Special situations of controversial, increased, or unknown cardiovascular risk -- Optimal management of old and new CV risk factors -- Angiographic narrowing prior to ST elevation MI. Are the lesions non-obstructive? -- Preventing future acute coronary events - Identify and treat vulnerable plaques or vulnerable, high risk patients? -- Treatment of diabetes and coronary artery disease -- Elevated triglycerides and atherosclerosis -- Patent foramen ovale and stroke -- Systolic hypertension in the elderly -- Section 2. Cardiovascular diagnosis -- CT angiography vs routine stress testing in patients with chest pain seen in the emergency room to exclude coronary artery disease -- Takotsubo cardiomyopathy- frequency, diagnosis and management -- Chest pain in women - evaluation and management -- Section 3. Cardiovascular management -- Myocardial infarction and "normal" coronary arteries on angiography -- Management of intractable angina when PCI or CABG is not an option -- Invasive management of CAD in patients on anticoagulants -- Managing intracoronary thrombus during PCI -- Optimal management of multivessel disease - PCI vs CABG vs medical therapy alone -- Appropriate therapy for severe left main disease -- Radial vs femoral procedures for angiography and PCI -- DAPT after stenting in stable and acute coronary syndromes - does the drug combination really matter? -- CAD management in patients with significant renal dysfunction or on dialysis -- What is the optimal stent design? -- Oral pharmacotherapy in the prevention of restenosis: prednisolone, rapamune, colchicine and cilostazol -- When should ablation be considered in the treatment of atrial fibrillation? -- Use of advanced and expensive cardiac procedures in the very elderly- Can or should we limit access? -- Cost benefits of TAVR- Should the indications be expanded?
520 $a This book considers several clinical and interventional topics for which there is either uncertainty, continued debate and/or no consensus based on current guidelines. Leading international experts explore each controversy, probing the existing evidence and current opinions. Each chapter outlines the unresolved issues and includes a balanced and scholarly discussion of the subject, concluding with possible solutions and learned opinions on the subject. While there are many guidelines in cardiology, new and on-going trials that address new treatments indicate that there are still many unanswered questions. Controversies in Cardiology provides a concise approach to aid busy cardiologists and trainees in choosing the most suitable management solutions and correctly applying these to their patients.
650 0 $a Cardiology. $3 861477
650 0 $a Heart $x Diseases. $3 708114
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Minimally Invasive Surgery. $3 894453
650 2 4 $a Cardiac Surgery. $3 894362
700 1 $a Ambrose, John A. $3 2163154
700 1 $a Rodriguez, Alfredo E. $3 2163155
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-20415-4
950 $a Medicine (Springer-11650)